InvestorsHub Logo
Followers 48
Posts 2221
Boards Moderated 1
Alias Born 01/28/2013

Re: Alleyba1 post# 23043

Sunday, 05/03/2015 10:21:08 PM

Sunday, May 03, 2015 10:21:08 PM

Post# of 24848

I think it will be profitable, particularly when business starts with China. Give bob time to implement his plan.everyone just sit back and relax:


How pathetically ironic, Alleyba. For the past two years, when rational voices were cautioning folks to take a "wait and see" approach and de-risk, you (yet another self-disclosed member of the homophobic criminal JOSEPH ZAMPETTI's CORE group) and all the other CORE con artists were hyping and pumping SCRC to high heaven, urging anyone and everyone of how "rock solid" SCRC was, how SCRC was a "blue chip" caliber stock that did not belong in pennyland, and how everyone needed to spend every last dollar they had to overload their portfolios with SCRC stock IMMEDIATELY (and to hold-hold-hold but never sell/trade any shares) because a gazillion different catalysts were comin' that would take the sp to $4 and beyond... ...have you so quickly forgotten the ridiculous "RapiMed China Launch Countdown Clock" that your CORE group created back in 2013 to pump the "imminent" launch of RapiMed in mainland China???

Give me a break. First, BS Schneiderman pumped mainland China. Then when it didn't launch within the 60-90 registration approval window that he had pumped, he weasel talked and changed his narrative, saying "Oh, it's Hong Kong". He even had the audacity to issue intentionally false PR's OVER A YEAR AGO stating that SCRC had obtained approval from Hong Kong and that it was now free to begin selling RapiMed in Hong Kong -- and now, over a year later, he is still backtracking and saying that Hong Kong approval is "imminent"...

...even in the original analyst report by SeeThruEquity, BS Schneiderman had claimed that RapiMed would launch in Hong Kong by 12/31/14, would launch in mainland China by 3/31/15, and then launch in numerous other countries by the end of 2015. And this RapiMed launch was stated by STE as a major reason why they set a price target of $1.20.

Just gotta love when people with un-disclosed financial conflicts of interest open their pieholes and quickly confirm to everyone why Section 17(b) of the Securities Act of 1933 was enacted and is so important...